4.2 Article

Time of Day of Vaccination Affects SARS-CoV-2 Antibody Responses in an Observational Study of Health Care Workers

Journal

JOURNAL OF BIOLOGICAL RHYTHMS
Volume 37, Issue 1, Pages 124-129

Publisher

SAGE PUBLICATIONS INC
DOI: 10.1177/07487304211059315

Keywords

COVID-19; SARS-CoV-2; HCW; Spike antibody; time of day

Funding

  1. NIH [K24-HL105664, P01-AG009975, R01-HL128538]
  2. Wellcome Investigator Award [200838/Z/16/Z]
  3. UK Medical Research Councilproject grant [MR/R022011/1]
  4. Chinese Academy of Medical Sciences Innovation Fund for Medical Science, China [2018-I2M-2-002]
  5. NCATS Harvard Clinical and Translational Science Center [5UL1TR002541-02]
  6. NIHR Oxford Biomedical Research Centre
  7. Wellcome [110110/Z/15/Z]
  8. MRC [MR/R022011/1] Funding Source: UKRI
  9. Wellcome Trust [200838/Z/16/Z] Funding Source: Wellcome Trust

Ask authors/readers for more resources

The COVID-19 pandemic presents unprecedented challenges to global public health, with vaccinations playing a crucial role in slowing down the spread of the virus and reducing disease severity. Factors such as vaccination timing, type, participant demographics, and days post-vaccination influence the antibody response, offering insights for optimizing vaccine efficacy against SARS-CoV-2.
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global crisis with unprecedented challenges for public health. Vaccinations against SARS-CoV-2 have slowed the incidence of new infections and reduced disease severity. As the time of day of vaccination has been reported to influence host immune responses to multiple pathogens, we quantified the influence of SARS-CoV-2 vaccination time, vaccine type, participant age, sex, and days post-vaccination on anti-Spike antibody responses in health care workers. The magnitude of the anti-Spike antibody response is associated with the time of day of vaccination, vaccine type, participant age, sex, and days post-vaccination. These results may be relevant for optimising SARS-CoV-2 vaccine efficacy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available